Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.90%) to 10309.22, DAX (0.46%) to 24491.06, CAC40 (0.29%) to 8238.17, STOXX 600 (1.05%) to 611.65

Feb 05 ,2026

  • Synopsis:

    • European equity markets ended lower. Follows a mixed to mostly higher close on Wednesday. Tech and media best performers after recent selloff; banks and basic resources outsized decliners.

    • Technology sector still in focus as sector recovers. Scrutiny on AI-related weakness and concentration risk, but there has also been focus on broadening-out trade. Attention today on central bank policy with ECB and BoE both leving policy on hold. The ECB kept its key rates unchanged for the fifth consecutive meeting at 2%. Emphasized uncertain outlook amid ongoing trade uncertainty and geopolitical tensions. Highlighted that updated assessment reconfirms that inflation should stabilize at 2% target in the medium term. Earlier, The BoE left key Bank Rate unchanged at 3.75% by narrower-than-expected 5-4 vote split. Governor Bailey said on basis of current evidence, likely to cut rates further.

    • In politics, UK PM Starmer under increased pressure after admitting he was warned about former US ambassador Mandelson's friendship with Epstein before appointing him. Labour MPs warn Starmer's days as leader may be numbered.

    • On the macro-front, big beat in German factory orders for December +7.8% m/m vs consensus (1.8%) and prior revised +5.7% from +5.6%, amid large orders, particularly in metal products and mechanical engineering sector. Germany January Construction PMI miss 44.7 vs consensus 50.5 and prior 50.3 while UK beat 46.4 vs consensus 42.0 and prior 40.1. French industrial production unexpectedly dropped (0.7%) m/m vs consensus +0.2% and prior revised +0.1% from (0.1%). Elsewhere, EZ December Retail Sales decline by (0.5%) m/m vs consensus (0.2%) and prior revised to +0.1% from +0.2%.

    • On the M&A newsflow, Rio Tinto (RIO.LN) and Glencore (GLEN.LN) have called off discussions around a potential merger. Very busy day for earnings, with a slew of bank updates from BNP Paribas (BNP.FP), BBVA (BBVA.SM) and Danske Bank (DANSKE.DC) whilst, in the DACH region, Siemens Healthineers (SHL.GR), Hannover Re (HNR1.GR) and Aurubis (NDA.GR) released their latest results. In the Nordics, Mearsk (MAERSK.B.DC) , Pandora (PNDORA.DC), Saab (SAAB.A.SS), Vestas (VWS.DC), Volvo Car (VOLCAR.B.SS), GN Store Nord (GN.DC), DNO (DNO.NO), Neste (NESTE.FH) and Sampo (SAMPO.FH) were among several other names from the region to report Q4/FY25 updates. In the UK, Vodafone (VOD.LN) and BT (BT.A.LN), together with Shell (SHEL.LN) and Anglo American (AAL.LN) were the main names. In the Netherlands, ArcelorMittal (MT.NA) reported FY numbers.

    • Looking ahead to tomorrow's EU econ-calendar, notable releases will include, amongst others, Germany Dec trade balance, industrial production, France Dec trade balance and UK Jan house price index - Halifax.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers:

        • Technology +0.87%, Media +0.47%, Food & Beverage +0.41%, Persnl & HHold Goods +0.26%, Telecom (0.22%), Chemicals (0.25%), Construct & Mtls (0.39%), Health Care (0.47%), Ind Goods & Svcs (0.55%), Real Estate (0.81%), Financial Svcs (0.86%), Utilities (1.04%)

      • Underperformers:

        • Banks (3.50%), Basic Resources (3.41%), Autos & Parts (2.58%), Oil & Gas (2.39%), Travel & Leisure (2.20%), Retail (1.12%), Insurance (1.06%)

    • Macro:

      • Central banks:

        • Monetary policy decisions -- ECB

        • ECB holds rates but it's not a 'non-event,' economists say -- CNBC

        • Bank of England leaves rates steady after tight vote, sterling falls -- Reuters

      • EU:

        • EU Aims to Sharpen Its Competitive Edge -- Bloomberg

        • The EU-India agreement is huge - and it illustrates the changing role of trade in a fractured world order -- Conversation

        • EU, Australia to meet in Brussels to pursue free trade deal -- Bloomberg

      • UK:

        • Once feted Mandelson becomes nightmare for weakened UK PM Starmer -- Reuters

        • UK to scrap more than £250Mn in planned physics project funding -- FT

        • Macron wants Britain to pay up to £2B to join EU's Ukraine weapons scheme -- Telegraph

      • Germany:

        • Germany unveils its first AI factory in boost for European digital sovereignty -- euronews

        • Merz Promises Gulf Countries Easier Access to Military Goods -- Bloomberg

      • France:

        • Macron sends his diplomatic adviser to Moscow -- LeMonde

      • Italy:

        • Italy's economy will grow by 0.7% in 2026 - forecast -- GMK

        • Italy steps up as the EU races to secure critical minerals -- Decode39

    • Company news:

      • Notable Gainers

        • +13.8% NOD.NO (Nordic Semiconductor NOK149.60, +18.10) -- earnings

        • +13.5% RAA.GR (Rational €748.50, +89.50) -- prelim earnings

        • +12.0% ATT.SS (Attendo SEK101.60, +10.90) -- earnings

        • +11.9% MILDEF.SS (MilDef Group NT$137.00, +14.60) -- earnings

        • +11.4% BACTI.B.SS (Bactiguard Holding SEK16.55, +1.70) -- earnings

        • +11.3% CEVI.SS (CellaVision SEK157.00, +16.00) -- earnings

        • +9.2% SVIK.SS (Studsvik SEK355.00, +30.00) -- earnings

        • +8.0% SOBI.SS (Swedish Orphan Biovitrum SEK387.00, +28.60) -- earnings

        • +7.0% CLA.B.SS (Cloetta SEK48.88, +3.20) -- target up at Nordea

        • +6.8% RUG.SS (Rugvista Group SEK66.20, +4.20) -- earnings

        • +6.7% PEAB.B.SS (Peab SEK99.00, +6.25) -- DNB Carnegie, Handelsbanken, SEB upgrades

        • +6.0% ACE.SS (Ascelia Pharma SEK2.76, +0.16) -- earnings

        • +5.6% PNDORA.DC (Pandora DKK541.20, +28.60) -- earnings

        • +5.4% SZG.GR (Salzgitter €50.10, +2.58) -- target up at Deutsche Bank

        • +5.4% FUM.LN (Futura Medical £0.01, -0.00) -- Futura Medical has been granted notice of allowance of its US continuation patent for Eroxon, WSD4000 until 2040

        • +5.1% DETEC.FH (Detection Technology €11.30, +0.55) -- earnings

        • +4.8% LOG.SM (Logista Integral €33.06, +1.54) -- earnings

        • +4.1% FSKRS.FH (Fiskars €12.60, +0.50) -- earnings; Vita reorganization

        • +3.8% TNIE.GR (tonies €10.94, +0.40) -- prelim earnings

        • +3.3% TBLD.LN (tinyBuild £0.08, -0.00) -- trading update

        • +3.3% STMN.SW (Straumann Holding CHF97.98, +3.14) -- read-across from US peer Align cited

        • +3.1% PNDX.B.SS (Pandox SEK198.00, +6.00) -- earnings

        • +3.1% MT.NA (ArcelorMittal €48.93, +1.47) -- earnings

        • +3.1% SLIGR.NA (Sligro Food Group €12.08, +0.36) -- earnings

        • +2.2% BILI.A.SS (Bilia SEK131.90, +2.90) -- earnings

        • +2.1% PTEC.LN (Playtech £2.88, +0.06) -- trading update

        • +2.0% SAP.GR (SAP €170.18, +3.28) -- first tranche of buyback initiated

        • +1.9% ASSA.B.SS (Assa Abloy SEK388.00, +7.40) -- earnings

      • Notable Decliners

        • -88.5% AKH.NO (Aker Horizons NOK0.04, -0.34) -- to liquidate and delist shares

        • -39.7% FRACTL.SS (Fractal Gaming Group SEK13.00, -8.55) -- earnings

        • -22.5% VOLCAR.B.SS (Volvo Car SEK22.93, -6.67) -- earnings

        • -20.1% CHEMM.DC (ChemoMetec DKK463.00, -116.50) -- earnings

        • -16.7% ITECH.SS (I-Tech SEK43.50, -8.70) -- earnings

        • -14.1% HDD.GR (Heidelberger Druckmaschinen €1.60, -0.26) -- earnings

        • -13.9% NORION.SS (Norion Bank SEK58.40, -9.40) -- earnings

        • -10.9% SOLAR.B.DC (Solar DKK201.00, -24.50) -- earnings

        • -9.9% NCC.B.SS (NCC SEK212.00, -23.20) -- earnings

        • -9.6% MYCR.SS (Mycronic SEK188.88, -19.97) -- earnings

        • -9.3% ROKO.B.SS (Röko SEK1,501.80, -154.80) -- earnings

        • -8.8% BBVA.SM (Banco Bilbao Vizcaya Argentaria €20.10, -1.93) -- earnings

        • -8.7% VWS.DC (Vestas Wind Systems DKK176.40, -16.75) -- earnings

        • -7.9% FSECURE.FH (F-Secure €1.68, -0.14) -- earnings

        • -7.3% ORX.SS (Orexo SEK27.20, -2.15) -- earnings

        • -6.5% RHM.GR (Rheinmetall €1,565.50, -108.50) -- pre-close call

        • -6.0% NWG.LN (NatWest Group £6.53, -0.42) -- Barclays and NatWest to be involved this week in the bidding process for Evelyn Partners at more than £2B for the wealth management group - Sky

        • -5.8% FRES.LN (Fresnillo £35.40, -2.20) -- Berneberg downgrade

        • -5.6% LLOY.LN (Lloyds Banking Group £1.06, -0.06) -- Barclays and NatWest to be involved this week in the bidding process for Evelyn Partners at more than £2B for the wealth management group - Sky

        • -5.6% PRIC.B.SS (Pricer SEK3.88, -0.23) -- earnings

        • -5.5% NEWA.B.SS (New Wave Group SEK104.00, -6.10) -- earnings

        • -5.2% FUTR.LN (Future Plc £4.86, -0.26) -- trading update

        • -5.1% AFRY.SS (AFRY AB SEK135.10, -7.30) -- earnings

        • -4.9% HIK.LN (Hikma Pharmaceuticals £15.59, -0.80) -- Brookfield Private Capital discloses it does not intend to make an offer for Hikma Pharmaceuticals

        • -4.8% KESKOB.FH (Kesko €20.84, -1.06) -- earnings

        • -4.7% VOD.LN (Vodafone Group £1.09, -0.05) -- earnings

        • -4.7% HLUN.B.DC (H. Lundbeck DKK36.98, -1.84) -- target cuts at Danske Bank, SEB

        • -4.5% AKTIA.FH (Aktia Bank €11.92, -0.56) -- earnings; impairments

        • -4.4% SHB.A.SS (Svenska Handelsbanken SEK140.45, -6.40) -- SEB downgrade

        • -4.1% NESTE.FH (Neste €20.63, -0.88) -- earnings

        • -3.7% MAERSK.B.DC (Maersk DKK15,385.00, -595.00) -- earnings

        • -2.9% NDA.GR (Aurubis €161.80, -4.90) -- earnings

        • -1.9% CPG.LN (Compass Group £21.65, -0.43) -- trading statement

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Aperam (APAM.NA), Lotus Bakeries (LOTB.BB), Orange Belgium (OBEL.BB)

        • DACHs: EMS-Chemie Holding (EMSN.SW), Vontobel Holding (VONN.SW), LEM Holding (LEHN.SW), All for One Group (A1OS.GR)

        • France: Societe Generale (GLE.FP), Ayvens (AYV.FP)

        • Finland: Kone (KNEBV.FH), Valmet (VALMT.FH), Yit (YIT.FH), Lindex Group (LINDEX.FH), Consti (CONSTI.FH),

        • Denmark: Ørsted (ORSTED.DC), Coloplast (COLO.B.DC), Gyldendal (GYLD.A.DC),

        • Norway: Kongsberg Gruppen (KOG.NO), Telenor (TEL.NO), Aker Solutions (AKSO.NO),

        • Sweden: Skanska (SKA.B.SS), Industrivarden (INDU.A.SS), Fastighets Balder (BALD.B.SS), Lagercrantz Group (LAGR.B.SS), Beijer Alma (BEIA.B.SS), Hoist Finance (HOFI.SS), Vitec Software Group (VIT.B.SS), MedCap (MCAP.SS), Boozt Fashion (BOOZT.SS), Duni (DUNI.SS), Knowit (KNOW.SS), Humana (HUM.SS), CTT Systems (CTT.SS), Xspray Pharma (XSPRAY.SS), CTEK (CTEK.SS), Infant Bacterial Therapeutics (IBT.B.SS), Duroc (DURC.B.SS), Balco Group (BALCO.SS), Dedicare (DEDI.SS), Netel Holding (NETEL.SS)

        • Southern Europe: Banco de Sabadell (SAB.SM), Banca Sistema (BST.IM)

  • Data:

    • Economics:

      • Eurozone Dec Retail Sales +1.3% y/y vs consensus +1.6% and prior revised to +2.4% from +2.3%

      • Germany

        • Dec Factory Orders m/m +7.8% vs consensus (1.8%) and prior revised to +5.7% from +5.6%

        • Jan Construction PMI 44.7 vs consensus 50.5 and prior 50.3

      • France Dec Industrial Production m/m (0.7%) vs consensus +0.2% and prior revised to +0.1% from (0.1%)

      • UK Jan Construction PMI 46.4 vs consensus 42.0 and prior 40.1

      • Italy Dec Retail Sales y/y +0.9% vs consensus +1.4% and prior +1.3%

    • Markets:

      • WTI Crude (26-Mar): ($1.92) or (2.95%) to $63.22

      • €-$ (0.0015) or (0.13%) to 1.1794

      • £-$ (0.0108) or (0.79%) to 1.3547

      • €-£ +0.0062 to 0.8709

      • S&P 500 (0.84%)

      • Performance year-to-date:

        • FTSE 100: +3.80%

        • DAX: +0.00%

        • CAC: +1.09%

        • MIB: +1.95%

        • Stoxx 600: +3.29%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE